Cargando…

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin

Leishmaniasis is a serious global health problem affecting many people worldwide. While patients with leishmaniasis can be treated with several agents, drug toxicicty and the emergence of resistant strains render available treatments ineffective in the long run. Inhibitors of the mammalian target of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khadir, Fatemeh, Shaler, Christopher R., Oryan, Ahmad, Rudak, Patrick T., Mazzuca, Delfina M., Taheri, Tahereh, Dikeakos, Jimmy D., Haeryfar, S. M. Mansour, Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122837/ https://www.ncbi.nlm.nih.gov/pubmed/30133440 http://dx.doi.org/10.1371/journal.pntd.0006701

Ejemplares similares

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2014)

Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasis
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Physical restraint mouse models to assess immune responses under stress with or without habituation
por: Ding, Jian Xiang, et al.
Publicado: (2021)

Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020)

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

Post-Genomics and Vaccine Improvement for Leishmania
por: Seyed, Negar, et al.
Publicado: (2016)

A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression
por: Johnson, Aaron L., et al.
Publicado: (2016)

Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)

Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum
por: Habibzadeh, Sima, et al.
Publicado: (2021)

Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Leishmania major Infected Macrophage Cells
por: SADEGHI, Somaye, et al.
Publicado: (2016)

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013)

Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997)
por: Van Nynatten, Logan R., et al.
Publicado: (2018)

Viral Bimolecular Fluorescence Complementation: A Novel Tool to Study Intracellular Vesicular Trafficking Pathways
por: Dirk, Brennan S., et al.
Publicado: (2015)

MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression
por: Shaler, Christopher R., et al.
Publicado: (2017)

CD1d- and MR1-Restricted T Cells in Sepsis
por: Szabo, Peter A., et al.
Publicado: (2015)

The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ
por: Anantha, Ram Venkatesh, et al.
Publicado: (2016)

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
por: Shahbazi, Mehdi, et al.
Publicado: (2015)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
por: Xu, Da-zhi, et al.
Publicado: (2010)

Regulation of mammalian target of rapamycin on ferroptosis: from mechanism to therapeutics in septic cardiomyopathy
por: Zhao, Guoyu, et al.
Publicado: (2022)

Leishmaniasis: Middle East and North Africa Research and Development Priorities
por: McDowell, Mary Ann, et al.
Publicado: (2011)

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging
por: Eskandar, Mahdieh, et al.
Publicado: (2020)

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice
por: Davarpanah, Elaheh, et al.
Publicado: (2020)

Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export
por: Woods, Matthew William, et al.
Publicado: (2014)

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite
por: Sadeghi, Somayeh, et al.
Publicado: (2015)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016)

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
por: Taslimi, Yasaman, et al.
Publicado: (2017)

DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Correction: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Building Research and Development Capacity for Neglected Tropical Diseases Impacting Leishmaniasis in the Middle East and North Africa: A Case Study
por: Rafati, Sima, et al.
Publicado: (2015)

The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor Tim-3 in infected CD4(+) T cells
por: Jacob, Rajesh Abraham, et al.
Publicado: (2021)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_un2aiuqt6l53mkhpui2qfpr0ii